Connection

Syed Hasan to Risk Assessment

Back to Details
This is a "connection" page, showing publications Syed Hasan has written about Risk Assessment.
Syed Hasan
Connection Strength
0.148
Risk Assessment
  1. Quality of adverse event reporting in clinical trials of remdesivir in patients with COVID-19. Eur J Clin Pharmacol. 2021 Mar; 77(3):435-437.
    View in: PubMed
    Score: 0.039
  2. Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: A meta-analysis. J Med Virol. 2021 02; 93(2):695-697.
    View in: PubMed
    Score: 0.039
  3. Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19. Am J Cardiovasc Drugs. 2020 Jun; 20(3):217-221.
    View in: PubMed
    Score: 0.038
  4. Consolidated Medication Review Algorithm to Improve Medications Use in Older Adults: Components, Scoring Scheme, and Implementation. J Am Med Dir Assoc. 2018 08; 19(8):717-718.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.